News and Announcements
MediKane: Two Products, Two Global Markets
- Published April 19, 2016 3:21PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Why you should invest in our growing business
GLOBAL DEMAND: MediKane sells a proven natural product that addresses the growing global problem of diabetes.
We also sell a related product that helps solve one of healthcare’s most intractable problems – constipation.
The diabetes product, NutriKane D, was launched in 2014 and is now sold throughout Australia, New Zealand and China. A US distributor is being appointed and established medical distributors in Singapore, Thailand and other Asian countries are asking for distribution licences.
NutriKane D is available through pharmacies, vitamin and health food stores. It is now one of Caruso’s Vitamin World’s top sellers.
Two global natural product marketers have approached MediKane requesting NutriKane D to be incorporated in their own branded solutions that they market to consumers both in Australian and overseas.
NutiKane D’s advantage over pharmaceutical treatments is that it is a safe natural product with no adverse side-affects, and while drugs have to be increased in strength over a patient’s life, NutriKane D maintains a constant benefit.
Our other product, NutriKane +, has been clinical tested to demonstrate that it reduces constipation significantly. Constipation delays the discharge 60% of post-operative hospital patients. Its target market is hospitals, convalescence and Aged Care homes.
To download the full article, please click on the link below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
